Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|March 12, 2026
IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancerJamie Hur, Massimo Fantini, Lidia Hernandez, et al.
The Journal of Urology|July 12, 2005
Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancerPhilip M Arlen, James L Gulley, Nushin Todd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory moleculesKwong Y Tsang, Claudia Palena, Junko Yokokawa, et al.
Journal of Pediatric Urology|February 11, 2020
Assessment of health literacy in adolescents with spina bifida and their caregivers: a multi-institutional studyMichelle A Lightfoot, Julie W Cheng, Xiaowen Hu, et al.
Cancer Immunology Research|July 2, 2015
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor BrachyuryChristopher R Heery, B Harpreet Singh, Myrna Rauckhorst, et al.
European Urology|December 24, 2014
A national multicenter phase 2 study of prostate-specific antigen (PSA) pox virus vaccine with sequential androgen ablation therapy in patients with PSA progression: ECOG 9802Robert S DiPaola, Yu-Hui Chen, Glenn J Bubley, et al.
The Journal of Urology|April 22, 2008
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling timePhilip M Arlen, Fernando Bianco, William L Dahut, et al.
Cancer Investigation|February 25, 2009
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agentsJeanny B Aragon-Ching, Yang-Min Ning, Clara C Chen, et al.
The Journal of Urology|April 20, 2010
A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancerWilliam D Figg, Sukyung Woo, Wenhui Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2020
Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal CancerRichard D Kim, Nilofer S Azad, Michael A Morse, et al.
Pageof 18